BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 19943035)

  • 1. Improving cardiac gap junction communication as a new antiarrhythmic mechanism: the action of antiarrhythmic peptides.
    Dhein S; Hagen A; Jozwiak J; Dietze A; Garbade J; Barten M; Kostelka M; Mohr FW
    Naunyn Schmiedebergs Arch Pharmacol; 2010 Mar; 381(3):221-34. PubMed ID: 19943035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human cardiac gap-junction coupling: effects of antiarrhythmic peptide AAP10.
    Hagen A; Dietze A; Dhein S
    Cardiovasc Res; 2009 Jul; 83(2):405-15. PubMed ID: 19176598
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The antiarrhythmic peptide rotigaptide (ZP123) increases gap junction intercellular communication in cardiac myocytes and HeLa cells expressing connexin 43.
    Clarke TC; Thomas D; Petersen JS; Evans WH; Martin PE
    Br J Pharmacol; 2006 Mar; 147(5):486-95. PubMed ID: 16415913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Desipramine prevents cardiac gap junction uncoupling.
    Jozwiak J; Dietze A; Grover R; Savtschenko A; Etz C; Mohr FW; Dhein S
    Naunyn Schmiedebergs Arch Pharmacol; 2012 Nov; 385(11):1063-75. PubMed ID: 22965471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase Calpha mediates the effect of antiarrhythmic peptide on gap junction conductance.
    Dhein S; Weng S; Grover R; Tudyka T; Gottwald M; Schaefer T; Polontchouk L
    Cell Commun Adhes; 2001; 8(4-6):257-64. PubMed ID: 12064599
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase in gap junction conductance by an antiarrhythmic peptide.
    Müller A; Gottwald M; Tudyka T; Linke W; Klaus W; Dhein S
    Eur J Pharmacol; 1997 May; 327(1):65-72. PubMed ID: 9185837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The anti-arrhythmic peptide AAP10 remodels Cx43 and Cx40 expression and function.
    Easton JA; Petersen JS; Martin PE
    Naunyn Schmiedebergs Arch Pharmacol; 2009 Jul; 380(1):11-24. PubMed ID: 19326099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local effects and mechanisms of antiarrhythmic peptide AAP10 in acute regional myocardial ischemia: electrophysiological and molecular findings.
    Jozwiak J; Dhein S
    Naunyn Schmiedebergs Arch Pharmacol; 2008 Nov; 378(5):459-70. PubMed ID: 18574580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacological modification of gap junction coupling by an antiarrhythmic peptide via protein kinase C activation.
    Weng S; Lauven M; Schaefer T; Polontchouk L; Grover R; Dhein S
    FASEB J; 2002 Jul; 16(9):1114-6. PubMed ID: 12039852
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myocardial gap junctions: targets for novel approaches in the prevention of life-threatening cardiac arrhythmias.
    Tribulová N; Knezl V; Okruhlicová L; Slezák J
    Physiol Res; 2008; 57 Suppl 2():S1-S13. PubMed ID: 18373398
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenergic control of cardiac gap junction function and expression.
    Salameh A; Dhein S
    Naunyn Schmiedebergs Arch Pharmacol; 2011 Apr; 383(4):331-46. PubMed ID: 21318337
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Remodeling of cardiac gap junctions and arrhythmias].
    Yu ZB; Sheng JJ
    Sheng Li Xue Bao; 2011 Dec; 63(6):586-92. PubMed ID: 22193455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of the new antiarrhythmic peptide ZP123 on epicardial activation and repolarization pattern.
    Dhein S; Larsen BD; Petersen JS; Mohr FW
    Cell Commun Adhes; 2003; 10(4-6):371-8. PubMed ID: 14681044
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancement of ventricular gap-junction coupling by rotigaptide.
    Lin X; Zemlin C; Hennan JK; Petersen JS; Veenstra RD
    Cardiovasc Res; 2008 Aug; 79(3):416-26. PubMed ID: 18430749
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The antiarrhythmic peptide analog rotigaptide (ZP123) stimulates gap junction intercellular communication in human osteoblasts and prevents decrease in femoral trabecular bone strength in ovariectomized rats.
    Jørgensen NR; Teilmann SC; Henriksen Z; Meier E; Hansen SS; Jensen JE; Sørensen OH; Petersen JS
    Endocrinology; 2005 Nov; 146(11):4745-54. PubMed ID: 16109789
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological modulation of connexin-formed channels in cardiac pathophysiology.
    De Vuyst E; Boengler K; Antoons G; Sipido KR; Schulz R; Leybaert L
    Br J Pharmacol; 2011 Jun; 163(3):469-83. PubMed ID: 21265827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maintenance of intercellular coupling by the antiarrhythmic peptide rotigaptide suppresses arrhythmogenic discordant alternans.
    Kjølbye AL; Dikshteyn M; Eloff BC; Deschênes I; Rosenbaum DS
    Am J Physiol Heart Circ Physiol; 2008 Jan; 294(1):H41-9. PubMed ID: 17982010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relating specific connexin co-expression ratio to connexon composition and gap junction function.
    Desplantez T; Grikscheit K; Thomas NM; Peters NS; Severs NJ; Dupont E
    J Mol Cell Cardiol; 2015 Dec; 89(Pt B):195-202. PubMed ID: 26550940
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Actions of the antiarrhythmic peptide AAP10 on intercellular coupling.
    Müller A; Schaefer T; Linke W; Tudyka T; Gottwald M; Klaus W; Dhein S
    Naunyn Schmiedebergs Arch Pharmacol; 1997 Jul; 356(1):76-82. PubMed ID: 9228193
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Connexin43 ablation in foetal atrial myocytes decreases electrical coupling, partner connexins, and sodium current.
    Desplantez T; McCain ML; Beauchamp P; Rigoli G; Rothen-Rutishauser B; Parker KK; Kleber AG
    Cardiovasc Res; 2012 Apr; 94(1):58-65. PubMed ID: 22287588
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.